• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 28-02-2026: Press Release

    28-02-2026 | 11:13 am

    Zydus secured USFDA final approvals for Ivermectin Tablets (USD 14.8 mn annual market) and Dapsone Tablets (USD 8.4 mn annual market). This expands their product portfolio, opening new revenue opportunities in the US for anti-parasitic and anti-infective drugs.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited